全文获取类型
收费全文 | 3396篇 |
免费 | 193篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 64篇 |
妇产科学 | 25篇 |
基础医学 | 429篇 |
口腔科学 | 60篇 |
临床医学 | 323篇 |
内科学 | 716篇 |
皮肤病学 | 108篇 |
神经病学 | 478篇 |
特种医学 | 139篇 |
外科学 | 575篇 |
综合类 | 32篇 |
预防医学 | 110篇 |
眼科学 | 83篇 |
药学 | 220篇 |
中国医学 | 7篇 |
肿瘤学 | 226篇 |
出版年
2023年 | 23篇 |
2022年 | 43篇 |
2021年 | 71篇 |
2020年 | 63篇 |
2019年 | 75篇 |
2018年 | 96篇 |
2017年 | 59篇 |
2016年 | 91篇 |
2015年 | 99篇 |
2014年 | 125篇 |
2013年 | 140篇 |
2012年 | 242篇 |
2011年 | 271篇 |
2010年 | 138篇 |
2009年 | 145篇 |
2008年 | 222篇 |
2007年 | 219篇 |
2006年 | 188篇 |
2005年 | 194篇 |
2004年 | 213篇 |
2003年 | 179篇 |
2002年 | 179篇 |
2001年 | 29篇 |
2000年 | 19篇 |
1999年 | 42篇 |
1998年 | 33篇 |
1997年 | 37篇 |
1996年 | 27篇 |
1995年 | 16篇 |
1994年 | 10篇 |
1993年 | 9篇 |
1991年 | 10篇 |
1990年 | 9篇 |
1989年 | 13篇 |
1988年 | 8篇 |
1987年 | 12篇 |
1985年 | 11篇 |
1983年 | 6篇 |
1982年 | 8篇 |
1980年 | 7篇 |
1978年 | 6篇 |
1931年 | 11篇 |
1930年 | 9篇 |
1929年 | 7篇 |
1928年 | 8篇 |
1927年 | 7篇 |
1926年 | 6篇 |
1923年 | 5篇 |
1921年 | 7篇 |
1913年 | 7篇 |
排序方式: 共有3614条查询结果,搜索用时 31 毫秒
51.
Drug Safety - Gastrointestinal bleeding (GIB) is the most common type of bleeding occurring in patients on oral anticoagulation. A meta-analysis of the landmark randomized controlled trials (RCTs)... 相似文献
52.
Dr. Johann Feilacher 《Neuropsychiatr》2012,26(4):201-203
53.
54.
55.
56.
57.
Dr. Johann Pidlich MD Friedrich Renner MD Adolf Ellinger PhD Manfred Huttinger PhD Margit Pavelka MD Alfred Gangl MD 《Digestive diseases and sciences》1996,41(7):1445-1451
The hydrophobic nonionic detergent Pluronic L-81 has been shown to lower plasma very-low-and low-density lipoprotein cholesterol, thus preventing diet-induced atherogenesis. The major effect of this agent is a pronounced interference with intestinal lipid metabolism. For studying mesenteric lymph lipoproteins during detergent exposure, a combined micromorphological and biochemical assessment of mucosa and lymph during steady-state lipid absorption was performed. Pluronic L-81 was infused intraduodenally at a constant rate in combination with mixed micellar solutions or saline in mesenteric lymph fistula rats. Pluronic L-81 impairs transepithelial lipid flux during fat absorption, trapping export lipids within the enterocytes and leading to a cytosolic and endoplasmic reticulum lipid accumulation sparing the Golgi region. Pluronic L-81 markedly (P<0.001) reduces mesenteric triglyceride, phospholipid, and total cholesterol secretion almost exclusively by a reduction of chylomicron formation. Chylomicron and very-low-density lipoprotein lipid composition was only insignificantly altered, except for somewhat higher phospholipid/triglyceride ratios. The chylomicron apoprotein pattern was almost unaffected. Thus, chylomicron formation decreased dramatically without major compositional alterations. The reduction of lipid and apoprotein secretion without particle augmentation is not in favour of a selective interference of Pluronic L-81 with intestinal apoprotein B-48 secretion.Parts of this work have been presented at the Annual Meeting of the American Gastroenterological Association, Washington, DC, May 1989, and published in abstract form (1). 相似文献
58.
59.
60.
BRL‐32872 is a new antiarrhythmic drug with balanced class‐III and class‐IV actions as categorized by the Vaughan‐Williams classification. BRL‐32872 blocks the rapid component of the cardiac delayed rectifier potassium channel IKr (IC50= 28 nM) and its molecular correlate HERG (“Human‐ether‐a‐go‐go related gene,” IC50 of 19.8 nM in cell lines) at low concentrations. It also inhibits the L‐type calcium current (ICa) at higher concentrations (IC50= 2.8 μM). This dual concentration‐dependent profile of action at higher concentrations may possibly prevent “torsades de pointes” ventricular arrhythmias, which is a dangerous side effect of many other class‐III antiarrhythmic drugs. With BRL‐32872, an excessive prolongation of the action potential duration and consecutive QTc prolongation is prevented by a concentration‐dependent increase of calcium channel block, resulting in the so‐called “bell‐shaped” profile of antiarrhythmic drug action. BRL‐32872 is very effective in the treatment of ventricular arrhythmias in animal models of cardiac ischemia. In the ischemic hearts of animals the drug significantly reduced early afterdepolarization and ventricular tachycardia. The antiarrhythmic effect of BRL‐32872 has not yet been demonstrated in humans. 相似文献